Publication: Open-label phase 1/2 study of vestronidase alfa for mucopolysaccharidosis VII.
dc.contributor.author | Jones, Simon | |
dc.contributor.author | Coker, Mahmut | |
dc.contributor.author | López, Antonio González-Meneses | |
dc.contributor.author | Sniadecki, Jennifer | |
dc.contributor.author | Mayhew, Jill | |
dc.contributor.author | Hensman, Pauline | |
dc.contributor.author | Jurecka, Agnieszka | |
dc.date.accessioned | 2023-02-09T11:40:36Z | |
dc.date.available | 2023-02-09T11:40:36Z | |
dc.date.issued | 2021-05-29 | |
dc.description.abstract | Vestronidase alfa is an enzyme replacement therapy for mucopolysaccharidosis VII (MPS VII). In this open-label, phase 1/2 study, three subjects with MPS VII received intravenous vestronidase alfa administered every other week (QOW) for 14 weeks (2 mg/kg), followed by 24-week forced-dose titration (1, 4, and 2 mg/kg QOW; 8 weeks each), 36-week continuation (2 mg/kg), and long-term extension (4 mg/kg). Vestronidase alfa was well tolerated and led to dose-responsive, sustained reductions in urinary glycosaminoglycan excretion. | |
dc.identifier.doi | 10.1016/j.ymgmr.2021.100774 | |
dc.identifier.issn | 2214-4269 | |
dc.identifier.pmc | PMC8178115 | |
dc.identifier.pmid | 34136357 | |
dc.identifier.pubmedURL | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8178115/pdf | |
dc.identifier.unpaywallURL | https://doi.org/10.1016/j.ymgmr.2021.100774 | |
dc.identifier.uri | http://hdl.handle.net/10668/18006 | |
dc.journal.title | Molecular genetics and metabolism reports | |
dc.journal.titleabbreviation | Mol Genet Metab Rep | |
dc.language.iso | en | |
dc.organization | Hospital Universitario Virgen del Rocío | |
dc.page.number | 100774 | |
dc.pubmedtype | Journal Article | |
dc.rights | Attribution 4.0 International | |
dc.rights.accessRights | open access | |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
dc.subject | Enzyme replacement therapy | |
dc.subject | MPS VII | |
dc.subject | Mucopolysaccharidosis VII | |
dc.subject | Phase 1/2 | |
dc.subject | Recombinant human β-glucuronidase | |
dc.subject | Vestronidase alfa | |
dc.title | Open-label phase 1/2 study of vestronidase alfa for mucopolysaccharidosis VII. | |
dc.type | research article | |
dc.type.hasVersion | VoR | |
dc.volume.number | 28 | |
dspace.entity.type | Publication |
Files
Original bundle
1 - 1 of 1